U.S. markets closed

Syneos Health, Inc. (SYNH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
58.06-0.18 (-0.31%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close58.24
Open58.56
Bid45.00 x 800
Ask58.26 x 800
Day's Range57.34 - 59.10
52 Week Range30.02 - 74.25
Volume341,911
Avg. Volume692,298
Market Cap6.036B
Beta (5Y Monthly)1.74
PE Ratio (TTM)32.75
EPS (TTM)1.77
Earnings DateOct 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est73.46
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
23% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Syneos Health (SYNH) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks

    Syneos Health (SYNH) Reports Next Week: Wall Street Expects Earnings Growth

    Syneos Health (SYNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Syneos Health® Launches Kinetic™ Omnichannel Capability to Accelerate Modern Customer Engagement
    GlobeNewswire

    Syneos Health® Launches Kinetic™ Omnichannel Capability to Accelerate Modern Customer Engagement

    Integrating Intelligence Across Channels, Technologies and Content Achieves Greater Precision, Efficiency and EffectivenessMORRISVILLE, N.C., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today introduced Kinetic, a modern customer engagement capability that makes fully integrated omnichannel solutions accessible to biopharmaceutical organizations. Powered by a team of data scientists, behavioral experts and channel strategists, Kinetic delivers the right message, to the right person, at the right moment to optimize performance. This advanced capability is already being deployed for biopharmaceutical companies of all sizes. Biopharmaceutical companies have long been challenged to obtain a clear, actionable and measurable view of all of their relationship-building efforts and the impact on customer behavior. Kinetic seeks to eliminate these silos and elevate performance by creating more personalized and meaningful integrated healthcare interactions, enabling customers to more effectively reach audiences.Kinetic delivers distinct advantages that only Syneos Health can, built on the foundation of the Company’s Biopharmaceutical Acceleration Model®, including integrated, end-to-end know-how; deep therapeutic knowledge; human behavior expertise; and a highly flexible, source-agnostic technology architecture called Dynamic Assembly®. This multiple option technology network is built with contemporary, aligned partners as opposed to relying solely on in-house technologies or solutions.“Accelerating therapies to market requires breaking down traditional silos and creating precise, customized and connected approaches across the product development lifecycle from clinical development through commercialization,” said Alistair Macdonald, Chief Executive Officer of Syneos Health. “With Kinetic, we seek to efficiently assess the nuances of each trial protocol or product launch and respond with flexible, right-sized tech- and data-enabled solutions to improve performance.”Kinetic is centered on Intelligence, Experience and Performance – three pillars that are mission-critical to success in today’s technology-enabled engagement landscape. The capability features advanced targeting, unified views of channel behavior, matrixed content, person-level relevant automation and performance analytics with the goal of exceeding program targets.A cornerstone of Kinetic is Digital Amplifier, a precise surround-sound digital overlay designed to amplify sales teams and existing call plans, synchronizing personal (face-to-face) engagement with smart, relevant non-personal (digital) outreach. This represents a hybrid, hyper-efficient way to amplify field relationships by targeting media to individual prescribers across digital channels with high-service follow-ups.“Kinetic employs a sophisticated, effective system for reaching HCPs that is specifically designed to enhance the impact of active sales teams. As the leading Commercial outsourcing provider, we’ve always recommended optimized solutions – during COVID-19 we’ve accelerated these efforts, advanced this capability and validated its impact,” said Michelle Keefe, President of Commercial Solutions at Syneos Health. “For example, for a product we helped launch during COVID-19, Digital Amplifier allowed us to consistently reach 80% of HCPs on the call plan when access was down industry-wide. More impressively, our program generated a double-digit lift in total prescriptions written by HCPs that were both called on by the field and received Digital Amplifier compared to those who were only called on by the field. This is one of many examples of the power of this capability.”Kinetic delivers personally relevant healthcare engagement, providing organizations of all sizes omnichannel fluency with the flexibility to access full-scale integration or point solutions. Learn more at syneoshealth.com/kinetic.About Syneos Health Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Our Company brings together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com.Syneos Health Investor Relations Contact: Syneos Health Press/Media Contact: Ronnie Speight Danielle DeForge Senior Vice President, Investor Relations Vice President, External Communications +1 919 745 2745 +1 202 210 5992 investor.relations@syneoshealth.com danielle.deforge@syneoshealth.com

  • GlobeNewswire

    Syneos Health Named to Forbes 2020 List of World’s Best Employers

    Company Ranks Highest Among Biopharmaceutical Outsourcing OrganizationsMORRISVILLE, N.C., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the Company has been named to the Forbes 2020 list of World’s Best Employers, ranking highest among biopharmaceutical outsourcing organizations. This recognition is realized just three years into the Company’s journey to create a leading insights-driven product development organization fueled by top talent and a collaborative culture. At Syneos Health employees work across clinical and commercial disciplines in sync, sharing data, insights and knowledge to deliver innovative, integrated solutions that change patients' lives. Syneos Health employs 24,000 people servicing biopharmaceutical companies in more than 110 countries who are dedicated to shortening the distance from lab to life®.“From day one, we aimed to create a new kind of Company – one with a transformative business model and a unique empowering culture to match. We looked to create an inclusive environment where bringing your authentic self to work is the norm and strategic problem solvers with a passion for accelerating the delivery of medicines to patients thrive,” said Alistair Macdonald, Chief Executive Officer, Syneos Health. “Thank you to our global workforce for the important life-changing work you do each day, and for the critical role you play in co-creating our culture.”The Company lives three fundamental Values including Challenge the Status Quo, Collaborate to Deliver Solutions and Passionate to Change Lives – all critical to delivering seamless product solutions. Employees are also provided continuous learning experiences as part of the organization’s Biopharmaceutical Acceleration Academy, including award-winning leadership and development programs and accreditation trainings.“This recognition is significant and a true moment of pride and reflection about how our employees feel about the Company we’re building together,” commented Lisa van Capelle, Chief Human Resources Officer, Syneos Health. “At Syneos Health we are committed to listening and learning from each other, hyper-collaboration and bringing our Total Selves to work where we support the emotional, physical and community wellbeing of our employees. We’re constantly looking for top talent who wants to help chart our next chapter.”Forbes and Statista Inc., the world-leading statistic portal and industry ranking provider, selected companies for the World’s Best Employers list based on anonymous independent surveys of more 160,000 employees in more than 58 countries. Participants were asked to rate their employers as well as other employers in the industry on topics such as gender equality, social responsibility, image, economic footprint, talent development and COVID-19 response. Over 5,000,000 data points were analyzed.View our Career Openings and Get to Know Our People and Culture * Learn about career opportunities at Syneos Health – including clinical, commercial and corporate careers, in rapidly growing areas such as oncology. * Follow us on LinkedIn to view our weekly Resilient Together video series, highlighting how our employees have adapted together during the pandemic to continue to deliver impact for our customers and patients.   * View our People with Purpose video series which shows what makes our colleagues tick and how it influences the important work we do each day to impact patient lives.About Syneos Health Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Our Company brings together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com.Syneos Health Investor Relations Contact: Ronnie Speight Senior Vice President, Investor Relations +1 919 745 2745 investor.relations@syneoshealth.com   Syneos Health Press/Media Contact: Danielle DeForge Vice President, External Communications +1 202 210 5992 danielle.deforge@syneoshealth.com